NERM
AGN

New England Research & Management’s Allergan plc AGN Stock Holding History

New England Research & Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,475
Closed -$241K – 173
2017
Q4 		$241K Sell
1,475
-3,515
-70% -$631K 0.17% 134
2017
Q3 		$1.02M Buy
4,990
+540
+12% +$126K 0.75% 53
2017
Q2 		$1.08M Buy
4,450
+2,175
+96% +$511K 0.8% 46
2017
Q1 		$544K Buy
2,275
+150
+7% +$34.9K 0.42% 80
2016
Q4 		$446K Sell
2,125
-275
-11% -$57K 0.35% 98
2016
Q3 		$553K Buy
2,400
+925
+63% +$226K 0.46% 76
2016
Q2 		$341K Buy
+1,475
New +$340K 0.29% 117

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

New England Research & Management's AGN Position: Q1 2018 in Review

New England Research & Management sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 1,475 shares — an estimated $241K sold.

New England Research & Management first reported a position in AGN in Q2 2016 and held it in 7 quarters. The position peaked at $1.08M in Q2 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • New England Research & Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • New England Research & Management sold 1,475 Allergan plc shares in Q1 2018, an estimated $241K.
  • New England Research & Management first reported a position in Allergan plc in Q2 2016 and held it in 7 quarters.
  • New England Research & Management's Allergan plc position peaked at $1.08M in Q2 2017.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on New England Research & Management's 13F filing for Q1 2018, filed 17 Apr 2018.